Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Therapeutic use of interleukins: experimental results.

× No keyword cloud information.

21 in total

1. Continuous culture of T cells cytotoxic for autologous human leukaemia cells.

Authors: J M Zarling; F H Bach
Journal: Nature Date: 1979-08-23 Impact factor: 49.962

2. Impairment of antigen-presenting cell function by ultraviolet radiation.

Authors: M I Greene; M S Sy; M Kripke; B Benacerraf
Journal: Proc Natl Acad Sci U S A Date: 1979-12 Impact factor: 11.205

3. Ultraviolet radiation inhibits alloantigen presentation by epidermal cells: partial reversal by the soluble epidermal cell product, epidermal cell-derived thymocyte-activating factor (ETAF).

Authors: D N Sauder; F P Noonan; E C DeFabo; S I Katz
Journal: J Invest Dermatol Date: 1983-06 Impact factor: 8.551

4. Antigen-presenting cell function in induction of helper T cells for cytotoxic T-lymphocyte responses: evidence for antigen processing.

Authors: O Weinberger; S Herrmann; M F Mescher; B Benacerraf; S J Burakoff
Journal: Proc Natl Acad Sci U S A Date: 1981-03 Impact factor: 11.205

5. Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma.

Authors: S E Krown; F X Real; S Cunningham-Rundles; P L Myskowski; B Koziner; S Fein; A Mittelman; H F Oettgen; B Safai
Journal: N Engl J Med Date: 1983-05-05 Impact factor: 91.245

6. Clearance of interleukin 2 from the blood of normal and T cell-depleted mice.

Authors: P F Mühlradt; H G Opitz
Journal: Eur J Immunol Date: 1982-11 Impact factor: 5.532

7. The fate of interleukin-2 after in vivo administration.

Authors: J H Donohue; S A Rosenberg
Journal: J Immunol Date: 1983-05 Impact factor: 5.422

8. Molecular signals in antigen presentation. I. Effects of interleukin 1 and 2 on radiation-treated antigen-presenting cells in vivo and in vitro.

Authors: A Tominaga; S Lefort; S B Mizel; J T Dambrauskas; R Granstein; A Lowy; B Benacerraf; M I Greene
Journal: Clin Immunol Immunopathol Date: 1983-11

9. Lyt-23+ cyclophosphamide-sensitive T cells regulate the activity of an interleukin 2 inhibitor in vivo.

Authors: C Hardt; M Röllinghoff; K Pfizenmaier; H Mosmann; H Wagner
Journal: J Exp Med Date: 1981-08-01 Impact factor: 14.307

10. Clearance rates and systemic effects of intravenously administered interleukin 2 (IL-2) containing preparations in human subjects.

Authors: C Bindon; M Czerniecki; P Ruell; A Edwards; W H McCarthy; R Harris; P Hersey
Journal: Br J Cancer Date: 1983-01 Impact factor: 7.640